Albany Molecular Research Inc
AMRI
AMRI was delisted on the 31st of August, 2017.
141 hedge funds and large institutions have $472M invested in Albany Molecular Research Inc in 2016 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 52 increasing their positions, 41 reducing their positions, and 26 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 41
7% less funds holding
Funds holding: 151 → 141 (-10)
24% less capital invested
Capital invested by funds: $622M → $472M (-$150M)
38% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 26
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
98% less call options, than puts
Call options by funds: $1.13M | Put options by funds: $73.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
+$4.59M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.26M |
| 3 |
Morgan Stanley
New York
|
+$4.02M |
| 4 |
ACM
Ashford Capital Management
Wilmington,
Delaware
|
+$3.57M |
| 5 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
+$2.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$7.48M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
-$6.93M |
| 3 |
PIP
Permian Investment Partners
Dallas,
Texas
|
-$4.2M |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$2.02M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.99M |
AMRI Hedge Fund Activity: Q1 2016 in Review
141 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q1 2016, worth a combined $472M — down 24% from $622M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of AMRI and 16 opened new positions — a net loss of 10 holders — while 41 trimmed existing stakes and 52 added.
The largest buyer was Skandinaviska Enskilda Banken (SEB), opening a new position worth an estimated $4.59M. The largest seller was Granite Investment Partners, exiting entirely with an estimated $7.48M sold.
- 141 institutional investors held Albany Molecular Research Inc (AMRI) as of Q1 2016, down from 151 in Q4 2015.
- Funds reported $472M of Albany Molecular Research Inc stock for Q1 2016, down 24% quarter-over-quarter.
- 16 funds opened new Albany Molecular Research Inc positions in Q1 2016 and 26 closed out, a net change of -10 holders.
- The largest Albany Molecular Research Inc buyer in Q1 2016 was Skandinaviska Enskilda Banken (SEB), an estimated $4.59M added.
- The largest Albany Molecular Research Inc seller in Q1 2016 was Granite Investment Partners, an estimated $7.48M sold.
Based on aggregated 13F filings for Q1 2016.